An observational study in Periodontal Diseases, Periodontal Diseases Inflammation and Retinal Thickening, sponsored by Zeliha Başak Çakır Erdil. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 20 Years to 54 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-05.
Sponsored by Zeliha Başak Çakır Erdil · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 160 studies in Periodontal Diseases with a site in Turkey — 25 open to participants now, 34 under way, none of them phase 3. Periodontal Diseases · Turkey.
Among the 160 studies in Periodontal Diseases with a site in Turkey, this one is the 50th largest by planned enrollment of the 91 observational ones that give a count, is one of 22 that started in 2026, is one of 91 observational ones, reaches primary completion later than 19 of the 33 other live ones, and was the 148th registered.
871 studies on the registry are indexed under Periodontal Diseases; 191 are open to participants now.
Browse Periodontal Diseases studies →25 of the 160 studies in Periodontal Diseases with a site in Turkey are open now. Recruiting first, the newest first:
Biruni University · Sites in Turkey
Ages 18–65 · Healthy volunteers
Saglik Bilimleri Universitesi · Sites in Turkey
Ages 18+ · Healthy volunteers
Recep Tayyip Erdogan University Training and Research Hospital · Sites in Turkey
Ages 18–65 · Healthy volunteers
Recep Tayyip Erdogan University Training and Research Hospital · Sites in Turkey
Ages 18–70 · Healthy volunteers
Saglik Bilimleri Universitesi · Sites in Turkey
Ages 18–65 · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 102 Periodontal Diseases studies recruiting now, 48 (47%) set no upper age limit and 42 (41%) stop at 75 or younger; 5 take children under 18; 59 take healthy volunteers.
This study: 20 Years to 54 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
160 studies; the count open now beside each. This study's row is marked.
First in 2012; this study’s year is marked. 22 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80 is below the median of 100 across 304 observational studies indexed under Periodontal Diseases.
Median enrollment 60 across the 69 interventional studies, 88 across the 91 observational. Of the 123 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 160 have an industry lead sponsor. The 10 most frequent:
Zeliha Başak Çakır Erdil is the lead sponsor of 4 studies on the registry; 1 is open to participants now.
Zeliha Başak Çakır Erdil has 1 study filed under Periodontal Diseases — fewer than ten, so there is no comparison to draw.
10 of the studies in Periodontal Diseases with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07312045Ömer Faruk OkumuşHALP Score, Blood-Based Inflammatory Indices, and Salivary MMP-8 in Periodontal Disease and Healing After Non-Surgical Therapy | 2026-11-25 |
| NCT07887204Istanbul UniversityAntibiotic Resistance Genes in Periodontitis | 2026-12 |
| NCT07146776Saglik Bilimleri UniversitesiTreatment of Intrabony Defects With Injectable Platelet-Rich Fibrin and Xenogenic Grafts | 2026-12-01 |
| NCT07802249Ravan MammadovPeriodontal Health in Adults Treated With Fixed Orthodontic Appliances or Clear Aligners | 2026-12-25 |
| NCT07944911Ordu UniversityChanges in Taurine Levels After Non-Surgical Periodontal Treatment and Their Association With Inflammatory and Apoptosis Marker | 2027-03 |
Add all 10 to your calendar (.ics) → With an account.
Among the 160 studies in Periodontal Diseases with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Advanced PeriodontitisIn this cross-sectional study, the relationship between periodontal disease severity and retinal and choroidal structural changes was evaluated using SD-OCT. Data from a total of 80 participants were examined. It was found that choroidal thickness increased and ganglion cell layer thickness decreased as periodontal disease severity increased, while no significant relationship was found in RNFL and IPL thicknesses. The findings support a possible association between periodontal disease and ocular structural changes.
Periodontal disease, by causing chronic inflammation, can affect not only oral tissues but also systemic organs. While the potential link between periodontal disease and eye diseases has attracted attention in recent years, data regarding retinal and choroidal structural changes are limited. In this study, periodontal clinical findings were compared with measurements of retinal nerve fiber layer (RNFL), ganglion cell layer (GCL), inner plexiform layer (IPL), and choroid thickness obtained using spectral-domain optical coherence tomography (SD-OCT) in a total of 80 individuals diagnosed with periodontal health, gingivitis, early periodontitis, and advanced periodontitis. The findings showed that choroidal thickness increased and GCL thickness decreased as the severity of periodontal disease increased. This study aims to contribute to a better understanding of the relationship between periodontal disease and ocular structural changes and to provide a basis for future prospective research.
Group 1: Periodontal Healthy
Participants with clinically healthy periodontal tissues and no evidence of gingivitis or periodontitis.
Group 2: Gingivitis
Participants diagnosed with gingivitis, presenting gingival inflammation without clinical attachment loss.
Group 3: Early Periodontitis
Participants diagnosed with early-stage periodontitis based on clinical periodontal examination.
Group 4: Advanced Periodontitis
Participants diagnosed with advanced periodontitis with greater periodontal tissue destruction.
The study population consisted of 80 systemically healthy, non-smoking adults who underwent comprehensive periodontal examination and spectral-domain optical coherence tomography (SD-OCT). Participants were classified into four groups according to their periodontal status (periodontally healthy, gingivitis, early periodontitis, and advanced periodontitis). All participants provided written informed consent before enrollment.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Systemically healthy adults. Non-smokers (no current or previous tobacco use). Participants who underwent optical coherence tomography (OCT) imaging. Participants who provided written and agreed to participate in the study.
Exclusion Criteria:
Presence of any systemic disease. Current or former smokers. Participants with incomplete clinical or OCT data. Individuals who did not provide written .
-
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Correlation Between Periodontal Disease Severity and Choroidal Thickness
The correlation between periodontal disease severity and choroidal thickness will be assessed using Spearman's correlation coefficient (rₛ). Periodontal disease severity will be assessed using probing pocket depth (PPD) and clinical attachment level (CAL), measured in millimeters (mm) using a periodontal probe. Choroidal thickness will be measured in micrometers (µm) using spectral-domain optical coherence tomography (SD-OCT).
Time frame: Baseline
Correlation Between Periodontal Disease Severity and Retinal Nerve Fiber Layer (RNFL) Thickness
The correlation between periodontal disease severity and retinal nerve fiber layer (RNFL) thickness will be evaluated. Periodontal disease severity will be assessed using clinical periodontal parameters, including probing pocket depth (PPD) and clinical attachment level (CAL), measured in millimeters (mm). RNFL thickness will be measured in micrometers (µm) using spectral-domain optical coherence tomography (SD-OCT). The correlation will be quantified using Spearman's correlation coefficient (rₛ).
Time frame: Baseline
Correlation Between Periodontal Disease Severity and Ganglion Cell Layer (GCL) Thickness
The correlation between periodontal disease severity and ganglion cell layer (GCL) thickness will be evaluated. Periodontal disease severity will be assessed using clinical periodontal parameters, including probing pocket depth (PPD) and clinical attachment level (CAL), measured in millimeters (mm). GCL thickness will be measured in micrometers (µm) using spectral-domain optical coherence tomography (SD-OCT). The correlation will be quantified using Spearman's correlation coefficient (rₛ).
Time frame: Baseline
Correlation Between Periodontal Disease Severity and Inner Plexiform Layer (IPL) Thickness
The correlation between periodontal disease severity and inner plexiform layer (IPL) thickness will be evaluated. Periodontal disease severity will be assessed using clinical periodontal parameters, including probing pocket depth (PPD) and clinical attachment level (CAL), measured in millimeters (mm). IPL thickness will be measured in micrometers (µm) using spectral-domain optical coherence tomography (SD-OCT). The correlation will be quantified using Spearman's correlation coefficient (rₛ).
Time frame: Baseline
Plan to share: No — Individual participant data will not be shared to protect participant confidentiality and privacy.
No publications or documents are linked to this record.
Start is estimated for Oct 2026; primary completion for Oct 2026, 0 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Zeliha Başak Çakır Erdil